Methyl 2-[3-(benzyloxy)phenyl]acetate

CAS : 62969-42-0

Ref. 3D-MCA96942

Informations sur le produit

• Nom: Methyl 2-[3-(benzyloxy)phenyl]acetate
• Synonymes: Methyl 3-(phenylmethoxy)benzeneacetate, 3-Benzyloxyphenylacetic acid methyl ester, Methyl [3-(benzyloxy)phenyl]acetate, Benzeneacetic acid, 3-(phenylmethoxy)-, methyl ester

Description

Methyl 2-[3-(benzyloxy)phenyl]acetate (MBPCA) is a patent-pending lead compound with potential pharmacological applications as an inhibitor of acetyl-coa carboxylase. MBPCA has been shown to reduce plasma triglyceride levels in subchronic studies and is being developed as a potential treatment for hypertriglyceridemia. MBPCA has been shown to be effective against high fat diet-induced obesity, increasing the level of fat oxidation and reducing body weight gain. The pharmacokinetic properties of MBPCA are currently being optimized, including parameters such as bioavailability, volume of distribution, and clearance.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 256.3 g/mol
• Formule: C₁₆H₁₆O₃
• Degré de pureté: Min. 95%